187 related articles for article (PubMed ID: 10788792)
1. Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization.
Goel A; Beresford GW; Colcher D; Pavlinkova G; Booth BJ; Baranowska-Kortylewicz J; Batra SK
J Biochem; 2000 May; 127(5):829-36. PubMed ID: 10788792
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.
Chauhan SC; Jain M; Moore ED; Wittel UA; Li J; Gwilt PR; Colcher D; Batra SK
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):264-73. PubMed ID: 15791435
[TBL] [Abstract][Full Text] [Related]
3. Binding characteristics and tumor targeting of a covalently linked divalent CC49 single-chain antibody.
Beresford GW; Pavlinkova G; Booth BJ; Batra SK; Colcher D
Int J Cancer; 1999 Jun; 81(6):911-7. PubMed ID: 10362138
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application.
Goel A; Colcher D; Baranowska-Kortylewicz J; Augustine S; Booth BJ; Pavlinkova G; Batra SK
Cancer Res; 2000 Dec; 60(24):6964-71. PubMed ID: 11156397
[TBL] [Abstract][Full Text] [Related]
5. The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.
Wittel UA; Jain M; Goel A; Chauhan SC; Colcher D; Batra SK
Nucl Med Biol; 2005 Feb; 32(2):157-64. PubMed ID: 15721761
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D
J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377
[TBL] [Abstract][Full Text] [Related]
7. Construction of divalent anti-keratin 8 single-chain antibodies (sc(Fv)(2)), expression in Pichia pastoris and their reactivity with multicellular tumor spheroids.
Jafari R; Holm P; Piercecchi M; Sundström BE
J Immunol Methods; 2011 Feb; 364(1-2):65-76. PubMed ID: 21093447
[TBL] [Abstract][Full Text] [Related]
8. Construction and evaluation of the tumor imaging properties of 123I-labeled recombinant and enzymatically generated Fab fragments of the TAG-72 monoclonal antibody CC49.
Tang Y; Yang S; Gariépy J; Scollard DA; Reilly RM
Bioconjug Chem; 2007; 18(3):677-84. PubMed ID: 17361988
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.
Goel A; Baranowska-Kortylewicz J; Hinrichs SH; Wisecarver J; Pavlinkova G; Augustine S; Colcher D; Booth BJ; Batra SK
J Nucl Med; 2001 Oct; 42(10):1519-27. PubMed ID: 11585867
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct.
Pavlinkova G; Colcher D; Booth BJ; Goel A; Batra SK
Cancer Immunol Immunother; 2000 Jul; 49(4-5):267-75. PubMed ID: 10941910
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
Pavlinkova G; Booth BJ; Batra SK; Colcher D
Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
[TBL] [Abstract][Full Text] [Related]
13. Single-chain antibodies in pancreatic cancer.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
[TBL] [Abstract][Full Text] [Related]
14. Charge-modified single chain antibody constructs of monoclonal antibody CC49: generation, characterization, pharmacokinetics, and biodistribution analysis.
Pavlinkova G; Beresford G; Booth BJ; Batra SK; Colcher D
Nucl Med Biol; 1999 Jan; 26(1):27-34. PubMed ID: 10096498
[TBL] [Abstract][Full Text] [Related]
15. Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.
Wu AM; Chen W; Raubitschek A; Williams LE; Neumaier M; Fischer R; Hu SZ; Odom-Maryon T; Wong JY; Shively JE
Immunotechnology; 1996 Feb; 2(1):21-36. PubMed ID: 9373325
[TBL] [Abstract][Full Text] [Related]
16. Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs.
Pavlinkova G; Colcher D; Booth BJ; Goel A; Wittel UA; Batra SK
Int J Cancer; 2001 Dec; 94(5):717-26. PubMed ID: 11745468
[TBL] [Abstract][Full Text] [Related]
17. Relative position of the hexahistidine tag effects binding properties of a tumor-associated single-chain Fv construct.
Goel A; Colcher D; Koo JS; Booth BJ; Pavlinkova G; Batra SK
Biochim Biophys Acta; 2000 Sep; 1523(1):13-20. PubMed ID: 11099853
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]